This competitive initiative supports excellent group leaders who are in the process of establishing their laboratories. The awarded early-career scientists receive 50,000 euros annually for three to five years and can apply for additional grants of up to 10,000 euros per year.

The name of the project is “MetaBreast - Metaverse for Breast Cancer Surgery”. Developed specifically in the field of breast cancer, it may one day also be applicable in other surgical contexts. For now, its goal is to “develop and test a new medical device to visualize malignant tissue in real time inside the patient’s breast and within the operating room”, states the document presenting the project. One of MetaBreast’s participants is the Champalimaud Foundation’s (CF) Breast Unit, represented by breast cancer surgeon Pedro Gouveia.  

Interview with Marta Carriço, nutritionist at the Champalimaud Foundation.

Marta Carriço is a nutritionist in the Risk Assessment Programme team (Programa de Oncorrisco) at the Champalimaud Clinical Centre. In this interview, she explains what is known – and not known – about the impact of eating habits on the prevention of oncological disease, strongly favouring the Mediterranean diet.

In the case of cancer (as in other diseases) any research study involving human volunteers that is intended to acquire medical knowledge about a potential new drug, vaccine or biological substance against a specific type of cancer – in which these are administered to a group of participants – is called a clinical trial.